|
rs2071536
|
PSMB9;TAP1
|
Oral Ulcer
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci.
|
30837455 |
2019 |
|
rs2071538
|
PSMB9;TAP1
|
Crohn Disease
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population.
|
23266558 |
2013 |
|
rs2071540
|
PSMB8;PSMB9;TAP1;PSMB8-AS1
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
|
19503088 |
2009 |
|
rs4148882
|
PSMB9;TAP1
|
Narcolepsy
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association database developed in the Japanese Integrated Database Project.
|
19629137 |
2009 |
|
rs991760
|
PSMB9;TAP1
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
|
19503088 |
2009 |
|
rs2071481
|
PSMB9;TAP1
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
|
rs2071538
|
PSMB9;TAP1
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
|
rs2071540
|
PSMB8;PSMB9;TAP1;PSMB8-AS1
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
|
rs1135216
|
PSMB9;TAP1
|
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
|
0.020 |
GeneticVariation |
BEFREE |
PSMB8 rs2071464 was associated with generalized and active vitiligo from Gujarat whereas TAP1 rs1135216 showed no association.
|
28700671 |
2017 |
|
rs1135216
|
PSMB9;TAP1
|
Vitiligo
|
|
0.020 |
GeneticVariation |
BEFREE |
PSMB8 rs2071464 was associated with generalized and active vitiligo from Gujarat whereas TAP1 rs1135216 showed no association.
|
28700671 |
2017 |
|
rs1135216
|
PSMB9;TAP1
|
Vitiligo
|
|
0.020 |
GeneticVariation |
BEFREE |
In conclusion, the TAP1-rs1135216 and PSMB9-rs17587 variants are significantly associated with vitiligo, and even one copy of these mutant alleles can influence the risk among Saudis.
|
25548428 |
2014 |
|
rs1135216
|
PSMB9;TAP1
|
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
|
0.020 |
GeneticVariation |
BEFREE |
In conclusion, the TAP1-rs1135216 and PSMB9-rs17587 variants are significantly associated with vitiligo, and even one copy of these mutant alleles can influence the risk among Saudis.
|
25548428 |
2014 |
|
rs1135216
|
PSMB9;TAP1
|
Allergic rhinitis (disorder)
|
|
0.010 |
GeneticVariation |
BEFREE |
Subgroup analysis by atopic types indicated significant association of TAP1 polymorphism rs1135216 with asthma in the allele, dominant and recessive models and with allergic rhinitis in the recessive model.
|
29416713 |
2018 |
|
rs1135216
|
PSMB9;TAP1
|
Asthma
|
|
0.010 |
GeneticVariation |
BEFREE |
Subgroup analysis by atopic types indicated significant association of TAP1 polymorphism rs1135216 with asthma in the allele, dominant and recessive models and with allergic rhinitis in the recessive model.
|
29416713 |
2018 |
|
rs760870035
|
PSMB9;TAP1
|
Vitiligo
|
|
0.010 |
GeneticVariation |
BEFREE |
In total 1320 cases of vitiligo (1050 generalized and 270 localized) and 752 healthy controls were studied for the PSMB9 exon 3 G/A single-nucleotide polymorphism (SNP), PSMB8 exon 2 C/A SNP and PSMB8 intron 6 G/T SNP at site 37 360 using polymerase chain reaction (PCR)-restriction fragment length polymorphism.
|
28207947 |
2018 |
|
rs760870035
|
PSMB9;TAP1
|
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
|
0.010 |
GeneticVariation |
BEFREE |
In total 1320 cases of vitiligo (1050 generalized and 270 localized) and 752 healthy controls were studied for the PSMB9 exon 3 G/A single-nucleotide polymorphism (SNP), PSMB8 exon 2 C/A SNP and PSMB8 intron 6 G/T SNP at site 37 360 using polymerase chain reaction (PCR)-restriction fragment length polymorphism.
|
28207947 |
2018 |
|
rs1057141
|
PSMB9;TAP1
|
Tuberculosis, Pulmonary
|
|
0.010 |
GeneticVariation |
BEFREE |
No significant association was found between TAP1 (rs1057141), TAP2 (rs2228396, rs67511411, rs141555015) variants and PTB.
|
26996113 |
2016 |
|
rs1135216
|
PSMB9;TAP1
|
Tuberculosis, Pulmonary
|
|
0.010 |
GeneticVariation |
BEFREE |
The rs1135216 G allele was associated with increased risk of PTB (OR=2.65, 95%CI=1.784-3.969, p<0.001).
|
26996113 |
2016 |
|
rs1135216
|
PSMB9;TAP1
|
Vitiligo vulgaris
|
|
0.010 |
GeneticVariation |
BEFREE |
Vitiligo vulgaris was the most common type of disease, associated with the DG (55%) and GG (46%) genotypes for rs1135216 and with the RH genotype (59%) for rs17587.
|
25548428 |
2014 |
|
rs735883
|
PSMB9;TAP1
|
Colorectal Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
We investigated whether single nucleotide polymorphisms (SNPs) in the TAP1 gene (rs735883) are associated with susceptibility to CRC in a Japanese population.
|
24803408 |
2014 |
|
rs1351383
|
PSMB9;TAP1
|
melanoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Two SNPs (rs1351383 and rs2127675) were associated with melanoma risk in the GenoMEL data set (P = 0.013 and 0.004, respectively), but failed in validation using the Australian data set.
|
23360169 |
2013 |